The #FDA emphasises their focus on post approval drug safety
This week an FDA report, "Advances in FDA's Safety Program for Marketed Drugs", has highlighted the resources, both time and money,..
Featured News - Drug Safety World
-
The brochure for the #Drugsafety Europe conference is now available! -
Post marketing safety: the industry’s key concern -
Risk communication with Reinerio A. Deza #drugsafety
 |
The brochure for the #Drugsafety Europe conference is now available!The new European pharmacovigilance legislation is the biggest regulatory change to how the industry develops human medicine since.. |
 |
Post marketing safety: the industry’s key concernI have been re-reviewing the drug safety survey results which have again proved interesting reading. Its a great way for us to keep up with what is happening in the industry as it allows safety colleagues to anonymously.. |
|
|
Risk communication with Reinerio A. Deza #drugsafetyReinerio A. Deza, MD, Head Global Pharmacovigilance, Cubist Pharmaceuticals spoke at the World Drug Safety Congress Americas last month on Risk Communication. He explained the purpose of risk communication as providing.. |
Institute of Medicines new drug safety recommendations
The Institute of Medicines, the evidence-based advisory committee for policymakers, health professionals, the private sector, and the..
Robin Geller, Baxter Healthcare Corporation, on the #Pharmacovigilance industry
Continuing with our series on the current pharmacovigilance industry we spoke with Robin Geller, Director of Risk Management and Safety Writing..
What’s being said at WDSC USA this week?
Well its been a busy few days for all involved in World Drug Safety Congress Americas this week in Boston. There have been some great..
Topics to be covered at #DrugSafety Europe
If you can’t make our Drug Safety USA event taking place next week, why not check out our European event coming up in September? The brochure..
Criteria for risk benefit balance
Roche’s Michael Forstner spoke at the World Drug Safety Congress Europe and Americas in 2011. Following up to his interview in the blog last..
EU PV legislation with Michael Forstner, #Roche
We spoke to Michael Forstner, Integrated Safety risk manager, Roche, before the upcoming World Drug Safety Congress Americas 2012. ..
for archived posts, see Categories
